Alan Wake 2 is great. 88% in PC Gamer great. Best Story 2023 great. It's Remedy taking all the lessons it's learnt across a long career and distilling them into something wonderful. And, apparently, not enough of us have bought it yet.
In the recently released Business Review for January-March 2024, Remedy CEO Tero Virtala wrote that—although it had sold 1.3 million copies at the start of February—the company had only recouped «a significant part of the marketing and development expenses» for Alan Wake 2. A significant part, but not all. Virtala pretty much reiterated that in a subsequent earnings call, where he also mentioned that Remedy had experienced an operating loss of €2.1 million in Q1 2024. Though it's worth mentioning the company did buy back Control in that time.
Which is a shame, as Alan Wake 2 was undoubtedly one of the best games of 2023, and certainly deserved a quicker turn to profitability than it's apparently gotten. Virtala doesn't seem too pessimistic about it, at least (then again, things probably have to get quite bad for the CEO to start screaming 'the end is nigh' in earnings calls), and notes that sales for the game have «continued with a high average price.»
The game has yet to «generate royalty revenue,» in contrast with other Remedy games like Control and Alan Wake Remastered, both of which have contributed to Remedy's overall royalties growing year-on-year. I wouldn't necessarily worry about that one too much, though: Alan Wake Remastered went through the exact same thing in Q1 of the year following its release.
On the whole, Remedy seems pretty buoyant about its future. Virtala dedicates a hefty chunk both of the business review and earnings call to talking up the possibilities opened up by acquiring the rights to Control, which means the company can now «freely decide on the future of our two established franchises, Control and Alan Wake.» Virtala says Remedy is currently exploring both self-publishing and partner publishing for future
Read more on pcgamer.com